CareLit · DOI-Nachweis · Aktuelle Neurologie
SWAP: the safety and tolerability of switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease
DOI 10.1055/s-0029-1238715
Bibliografische Angaben
Nachweis in CareLit
Autor:innenG Alva, M Farlow, C Sadowsky, S Brennan
ZeitschriftAktuelle Neurologie
Ausgabe10/2009
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Switching medications is common for many reasons, particularly safety/tolerability issues. The SWAP study (SWitch from Aricept to Patch) evaluates the safety/tolerability of two drug switching paradigms in AD: switching from donepezil to rivastigmine patch immediately versus after a 7-day wash-out. This study also evaluates the safety/tolerability of rivastigmine patch-memantine therapy. Hypothesis: Sw…
Zitieren
Zitierempfehlung
G Alva, M Farlow, C Sadowsky, S Brennan (2009) SWAP: the safety and tolerability of switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease. Aktuelle Neurologie (10). https://doi.org/10.1055/s-0029-1238715
Mit CareLit weiterarbeiten